On December 12, 2016, Reuters reported that Scott Gottlieb is a short list candidate for head of FDA.
Gottlieb, an MD, was a senior advisor at both CMS and FDA (2002-2004). He is currently a partner at New Enterprise Associates, a top-tier VC firm, and also a managing director at investment banking firm T.R. Winston. As a conservative, he is associated with the American Enterprise Institute. Gottlieb is a recurring op ed writer for Forbes (here) and for the Wall Street Journal (e.g. here, on FDA, August 2016; and here, on Obamacare, December 2016).
See the Reuters story, here. Gottlieb has 35K followers on Twitter, here.